220 related articles for article (PubMed ID: 34830923)
1. Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer.
Riaz N; Burugu S; Cheng AS; Leung SCY; Gao D; Nielsen TO
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830923
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints.
Chafe SC; Riaz N; Burugu S; Gao D; Leung SCY; Lee AF; Lee CH; Dedhar S; Nielsen TO
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804486
[TBL] [Abstract][Full Text] [Related]
3. Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Kluger HM; Dolled-Filhart M; Rodov S; Kacinski BM; Camp RL; Rimm DL
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):173-7. PubMed ID: 14734466
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.
Maher MG; Sapi E; Turner B; Gumbs A; Perrotta PL; Carter D; Kacinski BM; Haffty BG
Clin Cancer Res; 1998 Aug; 4(8):1851-6. PubMed ID: 9717811
[TBL] [Abstract][Full Text] [Related]
5. The c.1085A>G Genetic Variant of
Yeh YM; Hsu SJ; Lin PC; Hsu KF; Wu PY; Su WC; Chang JY; Shen MR
Clin Cancer Res; 2017 Oct; 23(20):6021-6030. PubMed ID: 28724665
[No Abstract] [Full Text] [Related]
6. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
7. High Expression of CSF-1R Predicts Poor Prognosis and CSF-1R
Wang X; Zhang J; Hu B; Qian F
Front Oncol; 2022; 12():850767. PubMed ID: 35444953
[TBL] [Abstract][Full Text] [Related]
8. High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.
Jia JB; Wang WQ; Sun HC; Zhu XD; Liu L; Zhuang PY; Zhang JB; Zhang W; Xu HX; Kong LQ; Lu L; Wu WZ; Wang L; Tang ZY
Oncologist; 2010; 15(7):732-43. PubMed ID: 20551429
[TBL] [Abstract][Full Text] [Related]
9. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
[TBL] [Abstract][Full Text] [Related]
10. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
11. Macrophage Susceptibility to Emactuzumab (RG7155) Treatment.
Pradel LP; Ooi CH; Romagnoli S; Cannarile MA; Sade H; Rüttinger D; Ries CH
Mol Cancer Ther; 2016 Dec; 15(12):3077-3086. PubMed ID: 27582524
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
13. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.
Zhang H; Almuqbil RM; Alhudaithi SS; Sunbul FS; da Rocha SRP
Int J Pharm; 2021 Apr; 598():120350. PubMed ID: 33545279
[TBL] [Abstract][Full Text] [Related]
14. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
[No Abstract] [Full Text] [Related]
15. Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer.
Saung MT; Muth S; Ding D; Thomas DL; Blair AB; Tsujikawa T; Coussens L; Jaffee EM; Zheng L
J Immunother Cancer; 2018 Nov; 6(1):118. PubMed ID: 30424804
[TBL] [Abstract][Full Text] [Related]
16. Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.
Flick MB; Sapi E; Perrotta PL; Maher MG; Halaban R; Carter D; Kacinski BM
Oncogene; 1997 May; 14(21):2553-61. PubMed ID: 9191055
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factor-1 receptor provides a growth advantage in epithelial cancer cell line A431 in the presence of epidermal growth factor receptor inhibitor gefitinib.
Niehus SE; Tran DDH; Mischak M; Koch A
Cell Signal; 2018 Nov; 51():191-198. PubMed ID: 30075184
[TBL] [Abstract][Full Text] [Related]
19. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
